Compare WF & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WF | COO |
|---|---|---|
| Founded | 1899 | 1980 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 15.5B |
| IPO Year | N/A | N/A |
| Metric | WF | COO |
|---|---|---|
| Price | $58.33 | $81.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $85.82 |
| AVG Volume (30 Days) | 56.0K | ★ 3.3M |
| Earning Date | 10-29-2025 | 12-04-2025 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | ★ 20.51 | N/A |
| EPS | ★ 2.97 | 1.87 |
| Revenue | ★ $8,054,512,650.00 | $4,092,400,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | $4.26 | $5.54 |
| P/E Ratio | ★ $6.47 | $43.53 |
| Revenue Growth | ★ 23.56 | 5.06 |
| 52 Week Low | $29.44 | $61.78 |
| 52 Week High | $59.88 | $104.47 |
| Indicator | WF | COO |
|---|---|---|
| Relative Strength Index (RSI) | 62.21 | 72.89 |
| Support Level | $57.48 | $75.25 |
| Resistance Level | $59.88 | $78.69 |
| Average True Range (ATR) | 1.39 | 2.48 |
| MACD | 0.50 | 0.47 |
| Stochastic Oscillator | 86.01 | 55.39 |
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.